首页> 美国卫生研究院文献>Genome Medicine >Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
【2h】

Towards an integrated proteomic and glycomic approach to finding cancer biomarkers

机译:寻求综合的蛋白质组学和糖组学方法以发现癌症生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Advances in mass spectrometry have had a great impact on the field of proteomics. A major challenge of proteomic analysis has been the elucidation of glycan modifications of proteins in complex proteomes. Glycosylation is the most structurally elaborate and diverse type of protein post-translational modification and, because of this, proteomics and glycomics have largely developed independently. However, given that such a large proportion of proteins contain glycan modifications, and that these may be important for their function or may produce biologically relevant protein variation, a convergence of the fields of glycomics and proteomics would be highly desirable. Here we review the current status of glycoproteomic efforts, focusing on the identification of glycoproteins as cancer biomarkers.
机译:质谱技术的进步对蛋白质组学领域产生了重大影响。蛋白质组学分析的主要挑战是阐明复杂蛋白质组中蛋白质的聚糖修饰。糖基化是蛋白质翻译后修饰中结构最精细和最多样化的类型,因此,蛋白质组学和糖组学已在很大程度上独立发展。然而,鉴于如此大量的蛋白质包含聚糖修饰,并且这些修饰对于其功能可能是重要的或可能产生生物学上相关的蛋白质变异,因此非常需要糖组学和蛋白质组学领域的融合。在这里,我们回顾了糖蛋白组学研究的现状,重点是糖蛋白作为癌症生物标志物的鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号